Caught Between a DRAM Lawsuit and €3.8 Billion in Subsidies, Aixtron Faces a Divergent Path
Published on 07/03/2026 at 02:55 | Redaktion boerse-global.de
The forces pulling at Aixtron right now could hardly be more opposed. On one side, a US antitrust lawsuit against the world’s largest memory-chip makers has sent shockwaves through the semiconductor supply chain, dragging equipment stocks down with it. On the other, Berlin has just unlocked a €3.8 billion funding package aimed squarely at the kind of advanced chip manufacturing Aixtron’s machines enable. The result is a stock caught between a brutal short-term sell-off and a politically backed long-term growth narrative.
The sell-off has been relentless. Aixtron shares closed at €45.05 on Thursday after seven consecutive losing sessions, during which they lost 13.37% of their value. From the 52-week high of €62.68 set on June 18, the stock has now given back 28.13%. The trigger was a class-action lawsuit filed in a US federal court accusing Samsung, SK hynix and Micron of artificially restricting DRAM supply. That news first hammered Asian markets — South Korea’s Kospi took a heavy hit as Samsung and SK hynix plunged — before the selling rippled through Europe. Aixtron tumbled 6.55% in a single session, and peers such as SUSS MicroTec, LPKF Laser and PVA TePla all suffered steep losses. Analysts now worry that the first-half AI rally may have priced in too much, too fast.
Yet for all the near-term pain, the drop comes from an extraordinary altitude. Aixtron’s 52-week low of €12.02 in September 2025 means the stock is still up roughly 275% from that nadir. The correction, in other words, is shaving gains from a rally that more than tripled the share price, not breaking the underlying trend. That trend is being buttressed by a major policy move. On July 2, Germany’s Federal Ministry for Economic Affairs formally notified the European Commission of the first 14 projects under the IPCEI AST programme, a Brussels-backed initiative to strengthen Europe’s microelectronics sovereignty. For domestic projects, up to €3.8 billion in state subsidies are on offer — and Aixtron is a direct beneficiary. Its MOCVD reactors are used to produce compound semiconductors from gallium nitride (GaN) and silicon carbide (SiC), materials critical for everything from power electronics to 5G infrastructure.
Should investors sell immediately? Or is it worth buying Aixtron?
Technical indicators suggest the selling is nearing exhaustion but has not yet flipped. The 14-day relative strength index stands at 33.9, just shy of the 30 threshold that typically signals oversold conditions. The stock now trades 14.8% below its 50-day moving average of €52.87, while remaining 51% above the 200-day line of €29.85 — a sign that the long-term uptrend is still intact, even if short-term momentum has snapped. With annualised volatility at 75.62%, swings of this magnitude are baked into the stock’s DNA.
Analysts are deeply split on what comes next. Barclays recently slapped a €39 price target on the stock, implying further downside. Jefferies, by contrast, sees fair value at €73 — a 62% premium to the current price. The divergence underscores the uncertainty surrounding Aixtron’s ability to translate order momentum into profits.
All eyes are now on July 30, 2026, when Aixtron releases its half-year results. That report will provide the hard data on order intake and profitability that could settle the debate — at least until the next shockwave hits.
Ad
Aixtron Stock: New Analysis - 3 July
Fresh Aixtron information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
